Jubilant Organosys


Jubilant Organosys Jubilant Organosys Jubilant Organosys Jubilant Organosys Jubilant Organosys Jubilant Organosys Jubilant Organosys Jubilant Organosys Jubilant Organosys Jubilant Organosys Jubilant Organosys Jubilant Organosys Jubilant Organosys Jubilant Organosys Jubilant Organosys Jubilant Organosys

Jubilant Organosys

You are here : Home > Businesses > Pharmaceuticals & Life Sciences Products & Services > Life Science Products > Generics > Dosage Forms

Jubilant’s journey up the value chain from a chemicals company to being a fully integrated Pharma company has now moved to the high-end dosage form business.

The business started itself by targeting the most regulated markets of US and Europe via two acquisitions; one in 2004 in Europe (PSI , Belgium) and another in 2005 in US (Cadista Pharmaceuticals Inc. erstwhile Trigen Labs)

PSI is engaged in Regulatory Affairs Services, Dossier Development, Licensing and Supply of Finished Dosage Form in Europe PSI, Belgium provides a full range of regulatory affairs services to European generic pharmaceutical companies.
Cadista is into the generic dosage forms business with a marketing office in Philadelphia and a US FDA approved, cGMP-compliant manufacturing facility in Maryland, USA.
The business then established two Greenfield facilities – R&D centre in Noida (India) and a manufacturing facility in Roorkee (India)
The total global team is around 400 techno-commercials spread across various GDF locations.
 
   
 
   
   

© Copyright Jubilant Organosys. All rights reserved.